登录 注册 会员服务 联系我们

Felbamate add-on therapy for drug-resistant focal epilepsy

  • Published:2019-08-01 Issue: Volume: Page:
  • ISSN:1465-1858
  • Container-title:Cochrane Database of Systematic Reviews
  • language:en
  • Short-container-title:

Author:

Shi Li Li1,Bresnahan Rebecca2,Martin-McGill Kirsty J23,Dong JianCheng4,Ni HengJian4,Geng JinSong4

Affiliation:

1. Evidence-based Medicine Center, Medical School of Nantong University; Nantong China

2. Institute of Translational Medicine, University of Liverpool; Department of Molecular and Clinical Pharmacology; Lower Lane Liverpool UK L9 7LJ

3. University of Chester; Department of Clinical Sciences and Nutrition; Faculty of Medicine, Dentistry and Life Sciences Chester UK

4. Medical School of Nantong University; Evidence-based Medicine Center; 19 Qixiu Road Nantong Jiangsu China 226001

Publisher

Wiley

Subject

Pharmacology (medical)

Reference32 articles.

1. Felbamate as add-on therapy in adult patients with partial drug- resistant epilepsy;Binelli;Bollettino - Lega Italiana Contro L'Epilessia,1999

2. Felbamate: a double-blind controlled trial in patients undergoing presurgical evaluation of partial seizures;Bourgeois;Neurology,1993

3. Felbamate for partial seizures: results of a controlled clinical trial;Leppik;Neurology,1991

4. Felbamate: a clinical trial for complex partial seizures;Theodore;Epilepsia,1991

5. Felbamate as add-on therapy;Li;European Neurology,1996

Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3